US Map / New Mexico
State NM

Clinical Trials in New Mexico

Recruiting clinical trials with at least one study location in New Mexico. Data updated daily from ClinicalTrials.gov.

Total Trials
60
Recruiting Now
60
← Back to US Map
Top Conditions in New Mexico
Malignant Solid Neoplasm (4)Melanoma (3)Acute Myeloid Leukemia (3)Lung Non-Small Cell Carcinoma (2)Breast Cancer (2)Sarcoma (2)Hematopoietic and Lymphatic System Neoplasm (2)Acute Lymphoblastic Leukemia (2)Atrial Fibrillation (2)Breast Carcinoma (1)Colorectal Carcinoma (1)Non-Hodgkin Lymphoma (1)
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT06272864 N/A
Recruiting
BostonGene and Exigent Genomic INsight Study
Condition
Breast Cancer
Enrollment
400 pts
Location
United States
Sponsor
BostonGene
View Trial →
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT06163326 Phase 3
Recruiting
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Partici...
Condition
Vitiligo
Enrollment
400 pts
Location
United States, Australia, Bulgaria
Sponsor
Pfizer
View Trial →
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT05983380 N/A
Recruiting
The Effect of Hand Exercises on Upper Limb Volume, Quality of Life, and Hand Fun...
Condition
Breast Cancer Lymphedema
Enrollment
50 pts
Location
United States
Sponsor
Texas Woman's University
View Trial →
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07357090 N/A
Recruiting
Carbon Dioxide Administration and Brain Waste Clearance
Condition
Traumatic Brain Injury
Enrollment
200 pts
Location
United States
Sponsor
Andrew Mayer
View Trial →
NCT06978127 N/A
Recruiting
Technology Assisted Collaborative Care Intervention to Improve Patient-centered ...
Condition
Chronic Kidney Disease Requiring Hemodialysis
Enrollment
424 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT07145229 Phase 2
Recruiting
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
Condition
Acute Gouty Arthritis
Enrollment
380 pts
Location
United States, Australia, China
Sponsor
Atom Therapeutics Co., Ltd
View Trial →
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
View Trial →
NCT06402331 Phase 2
Recruiting
FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-...
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
100 pts
Location
United States
Sponsor
Fusion Pharmaceuticals Inc.
View Trial →
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
View Trial →
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
View Trial →
NCT03136094 N/A
Recruiting
Suicide in Urban Natives: Detection and Networks to Combat Events
Condition
Suicide Prevention
Enrollment
698 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05458674 Phase 2
Recruiting
Tucatinib+Trastuzumab+Eribulin in HER2+ MBC
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Criterium, Inc.
View Trial →
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
View Trial →
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
NCT05040360 Phase 2
Recruiting
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendo...
Condition
Metastatic Malignant Neoplasm in the Liver
Enrollment
141 pts
Location
United States, Mexico, Uruguay
Sponsor
SWOG Cancer Research Network
View Trial →
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
View Trial →
Page 1 of 3 — 60 trials total
Next →